HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Galectin-3 and left ventricular reverse remodelling after surgical mitral valve repair.

AbstractAIMS:
Mitral valve repair in patients with functional mitral regurgitation (FMR) has been associated with beneficial left ventricular (LV) reverse remodelling. Recently, galectin-3 emerged as a marker of myocardial inflammation and fibrosis which may influence LV remodelling after surgery. The aim of the current study was to evaluate the association between pre-operative galectin-3 levels and LV reverse remodelling in heart failure patients with significant FMR who underwent mitral valve repair.
METHODS AND RESULTS:
In total, 42 heart failure patients (66 ± 10 years, 69% male) were evaluated. Plasma galectin-3 levels were assessed pre-operatively. Two-dimensional echocardiographic parameters were measured at baseline, and at 6 and 12 months after surgery. LV reverse remodelling was defined as a decrease in LV end-systolic volume ≥15% at 6 months follow-up. In total, 57% of the patients showed LV reverse remodelling. Patients with LV reverse remodelling showed significantly lower pre-operative galectin-3 levels (17.5 ± 5.6 vs. 23.7 ± 9.9 ng/mL, P = 0.009) compared with patients without LV reverse remodelling. In addition, patients with galectin-3 ≤18.2 ng/mL had a six-fold higher probability of showing LV reverse remodelling after surgery as compared with patients with levels >18.2 ng/mL (odds ratio 6.58, 95% confidence interval 1.32-33.33, P = 0.02).
CONCLUSION:
High pre-operative plasma galectin-3 is independently associated with the absence of LV reverse remodelling after mitral valve repair. Galectin-3 may be useful to identify heart failure patients who will need additional treatment to obtain beneficial LV reverse remodelling.
AuthorsKirsten A Kortekaas, Georgette E Hoogslag, Rudolf A de Boer, Martin M Dokter, Michel I M Versteegh, Jerry Braun, Nina Ajmone Marsan, Hariette F Verwey, Victoria Delgado, Martin J Schalij, Robert J M Klautz
JournalEuropean journal of heart failure (Eur J Heart Fail) Vol. 15 Issue 9 Pg. 1011-8 (Sep 2013) ISSN: 1879-0844 [Electronic] England
PMID23576289 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Biomarkers
  • Galectin 3
  • Peptide Fragments
  • pro-brain natriuretic peptide (1-76)
  • Natriuretic Peptide, Brain
Topics
  • Aged
  • Biomarkers (blood)
  • Echocardiography
  • Female
  • Follow-Up Studies
  • Galectin 3 (blood)
  • Heart Failure (diagnostic imaging, physiopathology, surgery)
  • Humans
  • Male
  • Middle Aged
  • Mitral Valve Annuloplasty (methods)
  • Mitral Valve Insufficiency (diagnostic imaging, physiopathology, surgery)
  • Natriuretic Peptide, Brain (blood)
  • Peptide Fragments (blood)
  • Ventricular Remodeling (physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: